Search

CytoSorbents Corp

Abierto

SectorSanidad

5.71

Resumen

Variación precio

24h

Actual

Mínimo

5.71

Máximo

5.71

Métricas clave

By Trading Economics

Ingresos

-4.4M

-9.5M

Ventas

769K

9.6M

BPA

-0.07

Margen de beneficios

-99.107

Empleados

129

EBITDA

547K

-3.3M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-86.96% downside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

19M

Apertura anterior

5.71

Cierre anterior

5.71

Noticias sobre sentimiento de mercado

By Acuity

70%

30%

296 / 339 Clasificación en Healthcare

CytoSorbents Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 sept 2026, 19:16 UTC

News

Cytosorbents Corp shares are higher as initial jobless claims fell to 196k and the Philadelphia Fed Manufacturing Index exceeded forecasts with a reading of 37.8.

16 sept 2026, 19:03 UTC

Cytosorbents Corp shares fell sharply, trading significantly lower since Tuesday's close and remaining well below the 20-day moving average.

15 sept 2026, 20:01 UTC

Cytosorbents Corp shares rebounded today, closing higher after a series of lower closes, amid broader market sentiment affected by a decline in the NY Empire State Manufacturing Index.

14 sept 2026, 20:02 UTC

Cytosorbents Corp shares are lower today, continuing a decline since Friday amid broader market concerns over rising crude oil prices and supply issues.

10 sept 2026, 17:46 UTC

News

CytoSorbents Corp shares are declining amid ongoing concerns about regulatory approval processes, despite announcing participation in the H.C. Wainwright conference.

9 sept 2026, 22:16 UTC

Shares of Cytosorbents Corp. traded higher during after-market hours, despite retracing from earlier gains and remaining below its 20-day moving average.

8 sept 2026, 20:01 UTC

Event

Cytosorbents Corp shares are higher following a 1-for-20 reverse stock split, showing strong momentum since Friday's close despite remaining below the 20-day moving average.

4 sept 2026, 23:20 UTC

Event

Cytosorbents Corp shares fell sharply in after-market hours following a reverse stock split of 1 for 20, trading significantly below their 20-day moving average.

3 sept 2026, 20:02 UTC

News

Cytosorbents Corporation shares are lower as the company announced a one-for-twenty reverse stock split to meet Nasdaq's minimum bid price requirement of $1.00.

2 sept 2026, 23:01 UTC

Cytosorbents Corp shares are lower in after-market trading, following significant volatility and amid heightened market sentiment from escalating U.S.-Iran tensions.

1 sept 2026, 20:01 UTC

Cytosorbents Corp shares are lower today, reflecting a modest decline since Monday's close. Broader market concerns may be influencing investor sentiment.

31 ago 2026, 21:01 UTC

Cytosorbents Corp shares are lower in after-market hours, continuing a five-session decline amid broader market pressures from hawkish Fed commentary.

28 ago 2026, 21:01 UTC

Cytosorbents Corp shares are lower in after-market trading after a volatile session, having declined following an initial rise earlier today. No specific news was identified.

27 ago 2026, 19:36 UTC

Cytosorbents Corp shares are lower today, reflecting broader market declines amid inflation data and speculation over potential Federal Reserve interest rate hikes.

26 ago 2026, 19:16 UTC

Cytosorbents Corp shares are higher amid notable volatility during Wednesday's session, fluctuating significantly while remaining in the middle of their one-month trading range.

25 ago 2026, 19:02 UTC

Cytosorbents Corp's shares are lower today, reversing earlier gains amid notable volatility. The stock has declined since Monday's close.

24 ago 2026, 21:01 UTC

Cytosorbents Corp shares are lower in after-market trading amid unusual volatility, despite earlier gains that pushed the stock near its one-month trading range.

21 ago 2026, 20:01 UTC

Cytosorbents Corp shares are higher today, continuing a strong upward trend since Thursday's close amid positive market sentiment and related equity gains.

20 ago 2026, 23:01 UTC

Cytosorbents Corp shares are lower in after-market hours, continuing a decline amid broader market pressure from disappointing sales growth at Walmart Inc.

18 ago 2026, 20:06 UTC

Cytosorbents Corp shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and persistent inflation concerns. No specific news was identified.

17 ago 2026, 19:36 UTC

Cytosorbents Corp shares are lower today amid rising Treasury yields and inflation concerns. The stock remains above its 20-day moving average.

14 ago 2026, 20:06 UTC

Cytosorbents Corp shares are higher today, continuing a notable upward trend despite mixed market sentiment and no specific company news identified.

13 ago 2026, 19:16 UTC

Cytosorbents Corp shares are higher today, reflecting routine performance and buoyed by overall market sentiment, despite no specific news driving the movement.

12 ago 2026, 19:46 UTC

Cytosorbents Corp is trading higher, building on gains since Tuesday's close. Broader market sentiment is positive amid favorable inflation data and strong tech earnings.

11 ago 2026, 22:01 UTC

Cytosorbents Corp shares are higher in after-market trading, following notable activity after the market closed, despite no specific company news identified.

10 ago 2026, 19:21 UTC

News

Cytosorbents Corp shares are higher, driven by gains in the Health Care Equipment sector. The company reported Q2 revenue of $9.63 million, exceeding forecasts.

7 ago 2026, 20:51 UTC

Cytosorbents Corp shares declined in after-hours trading, continuing lower since Friday's close, with no specific news identified to explain the movement.

6 ago 2026, 19:16 UTC

Cytosorbents Corp shares are higher during Thursday's session, continuing a strong upward trend since Wednesday's close, with no specific news identified for the increase.

5 ago 2026, 22:06 UTC

Cytosorbents Corp shares are higher in after-market trading, reaching a high of 2.63% following an initial dip. The stock remains above its 20-day moving average.

4 ago 2026, 21:01 UTC

Cytosorbents Corp shares are higher in after-market trading amid positive market sentiment linked to U.S.-Iran negotiations and declining crude oil prices.

Comparación entre iguales

Cambio de precio

CytoSorbents Corp previsión

Precio Objetivo

By TipRanks

-86.96% descenso

Estimación a 12 Meses

Media 0.75 USD  -86.96%

Máximo 0.75 USD

Mínimo 0.75 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CytoSorbents Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

296 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CytoSorbents Corp

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.